CL2A (TFA)
Référence HY-128945A-10mg
Conditionnement : 10mg
Marque : MedChemExpress
| Description |
CL2A TFA is a claevable complicated PEG8- and triazole-containing PABC-peptide-mc linker. CL2A TFA is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond. Labetuzumab govitecan used this linker[1]. |
|---|---|
| In Vitro |
ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. |

